In line with this, several lines of research suggest that post-COVID-19 may involve persistent (neuro) inflammation, indicated by increased levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-17A (Ceban et al., 2022; Monje and Iwasaki, 2022). This evidence concerns the gene IL17A and COVID-19.